Apellis Pharmaceuticals, Inc., is a global biopharmaceutical company
that is committed to leveraging courageous science, creativity, and
compassion to deliver life-changing therapies. Leaders in Complement,
at the forefront of targeted C3 therapies, we aim to develop
transformative therapies for a broad range of debilitating diseases that
are driven by uncontrolled or excessive activation of the complement
cascade, including those within hematology, ophthalmology,
nephrology, and neurology.
Additional Info
First-time Exhibitor:
No